• Latest Posts

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

Weekly Roundup 24 Nov 2023

Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA 

M&As: what’s up with the ADC buying spree?

Weekly Roundup 10 Nov 2023

Korro Bio and Frequency’s merger; Lexeo’s $100 million IPO; Gate Biosciences new class of drugs

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

Biogen acquiring Reata Pharmaceuticals for $7.3B

Sosei Heptares hails ‘transformational’ acquisition

Korro Bio and Frequency Therapeutics to merge